Departments of Dermatology.
Pathology, and.
Am J Dermatopathol. 2022 Jun 1;44(6):442-448. doi: 10.1097/DAD.0000000000002053. Epub 2022 Mar 22.
Histological transformation (HT) is an exceptionally uncommon and poorly understood event where a low-grade or indolent B-cell lymphoma transforms into a more aggressive entity, typically diffuse large B-cell lymphoma (DLBCL). The pathogenesis is unclear; however, HT is associated with a worse prognosis. This article reports a unique case of marginal zone lymphoma (MZL) limited to skin/subcutis (confirmed with PET-CT) that subsequently developed DLBCL, followed by nodal MZL. We explored phenotypic, molecular genetic, and cytogenetic findings in subcutaneous MZL with HT to DLBCL and subsequent progression to systemic MZL. Shared clonal peaks between the tumors were demonstrated through immunoglobulin heavy chain PCR, and genomic microarray analysis revealed both unique genomic abnormalities and shared regions of copy-neutral loss of heterozygosity in all specimens. BCL-2 expression was present in the original subcutaneous MZL, lost on conversion to Primary cutaneous diffuse large B cell lymphoma (PCDLBCL)-NOS, and regained during subsequent transformation to systemic MZL. The PCDLBCL-NOS did not demonstrate FISH rearrangements for MYC, BCL2, and BCL6. Here, we describe the histologic, immunophenotypic, and cytogenetic abnormalities of the clonally related transformation of subcutaneous MZL, PCDLBCL-NOS, and eventual systemic MZL. The predominantly subcutaneous presentation of MZL may be associated with a more aggressive outcome and raises consideration for careful evaluation of patients who present with this pattern.
组织学转化(HT)是一种非常罕见且尚未被充分了解的事件,在此过程中,低级或惰性 B 细胞淋巴瘤转化为更具侵袭性的实体瘤,通常为弥漫性大 B 细胞淋巴瘤(DLBCL)。其发病机制尚不清楚;然而,HT 与预后较差相关。本文报告了一例独特的边缘区淋巴瘤(MZL),仅局限于皮肤/皮下组织(通过 PET-CT 证实),随后发展为 DLBCL,继而发展为结内 MZL。我们探讨了 HT 后发生 DLBCL 以及随后进展为全身性 MZL 的皮下 MZL 的表型、分子遗传学和细胞遗传学发现。通过免疫球蛋白重链 PCR 证明了肿瘤之间存在共享的克隆峰,基因组微阵列分析显示,所有标本均存在独特的基因组异常和共享的拷贝中性杂合性丢失区域。BCL-2 在原始皮下 MZL 中表达,在转化为原发性皮肤弥漫性大 B 细胞淋巴瘤(PCDLBCL-NOS)时丢失,随后在向系统性 MZL 转化时恢复。PCDLBCL-NOS 未显示 MYC、BCL2 和 BCL6 的 FISH 重排。在这里,我们描述了皮下 MZL、PCDLBCL-NOS 和最终系统性 MZL 的克隆相关转化的组织学、免疫表型和细胞遗传学异常。MZL 主要表现为皮下形式可能与更具侵袭性的结果相关,并需要仔细评估表现出这种模式的患者。